Related content

RECIST 1.1 and serum thyroglobulin measurements in the evaluation of responses to sorafenib in patients with radioactive iodinerefractory differentiated thyroid carcinoma

By        

Oncology Letters, Vol. 6, Iss. 2, 2013-01 ,pp. : 480-486

Spandidos Publications

Access to resources Recommend Favorite

Risk factor analysis for central nodal metastasis in papillary thyroid carcinoma

By  

Oncology Letters, Vol. 9, Iss. 1, 2015-01 ,pp. : 103-107

Spandidos Publications

Access to resources Recommend Favorite

Thyroglobulin Measurement and Postablative Iodine-131 Total Body Scan After Total Thyroidectomy for Differentiated Thyroid Carcinoma in Patients with No Evidence of Disease

By Tenenbaum F.   Corone C.   Schlumberger M.   Parmentier C.  

European Journal of Cancer, Vol. 32, Iss. 7, 1996-06 ,pp. : 1262-1262

Elsevier

Access to resources Recommend Favorite

Risk factors for medullary thyroid carcinoma: a pooled analysis

By Negri E.  

Cancer Causes and Control, Vol. 13, Iss. 4, 2002-05 ,pp. : 365-372

Springer Publishing Company

Access to resources Recommend Favorite

Serum Albumin as a Significant Prognostic Factor for Patients with Gastric Carcinoma

By Oñate-Ocaña Luis   Aiello-Crocifoglio Vincenzo   Gallardo-Rincón Dolores   Herrera-Goepfert Roberto   Brom-Valladares Rocío   Carrillo José   Cervera Eduardo   Mohar-Betancourt Alejandro  

Annals of Surgical Oncology, Vol. 14, Iss. 2, 2007-02 ,pp. : 381-389

Springer Publishing Company

Access to resources Recommend Favorite